Wall Street Zen upgraded shares of Zhongchao (NASDAQ:ZCMD – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning.

Separately, Weiss Ratings raised Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Get Our Latest Analysis on Zhongchao

Shares of ZCMD stock opened at $1.08 on Friday. Zhongchao has a 12 month low of $0.80 and a 12 month high of $967.20. The company’s fifty day moving average price is $1.95 and its two-hundred day moving average price is $123.01.

(Get Free Report)

Zhongchao Inc provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand.

• Five stocks we like better than Zhongchao
• Quantum Earnings Week: Winners and Losers Are Finally Emerging
• Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
• Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
• AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish

Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.